These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11182286)

  • 21. Outcome of children with opsoclonus-myoclonus regardless of etiology.
    Hammer MS; Larsen MB; Stack CV
    Pediatr Neurol; 1995 Jul; 13(1):21-4. PubMed ID: 7575843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Opsoclonus-myoclonus syndrome in patient with ovarian cancer].
    Rubio Nazábal E; Marey López J; Avarez Pérez P; López Facal S; Alonso Magdalena L
    An Med Interna; 2003 Jul; 20(7):370-2. PubMed ID: 12892556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapeutic approaches to paraneoplastic neurological disorders.
    Blaes F
    Expert Opin Biol Ther; 2002 Apr; 2(4):419-30. PubMed ID: 11955279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Increased Immunosuppression on Developmental Outcome of Opsoclonus Myoclonus Syndrome (OMS).
    Mitchell WG; Wooten AA; O'Neil SH; Rodriguez JG; Cruz RE; Wittern R
    J Child Neurol; 2015 Jul; 30(8):976-82. PubMed ID: 25342308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Plasmapheresis and immunosuppressive drugs in the treatment of multiple sclerosis].
    Cendrowski W
    Neurol Neurochir Pol; 1984; 18(3):259-62. PubMed ID: 6390235
    [No Abstract]   [Full Text] [Related]  

  • 26. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.
    Rudnick E; Khakoo Y; Antunes NL; Seeger RC; Brodeur GM; Shimada H; Gerbing RB; Stram DO; Matthay KK
    Med Pediatr Oncol; 2001 Jun; 36(6):612-22. PubMed ID: 11344492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosuppressive therapy and plasmapheresis in rapidly progressive glomerulonephritis associated with bacterial endocarditis.
    Rovzar MA; Logan JL; Ogden DA; Graham AR
    Am J Kidney Dis; 1986 May; 7(5):428-33. PubMed ID: 3706297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paraneoplastic opsoclonus-myoclonus syndrome associated with malignant fibrous histiocytoma: neuropathological findings.
    Zámecník J; Cerný R; Bartos A; Jerábek J; Bojar M
    Cesk Patol; 2004 Apr; 40(2):63-7. PubMed ID: 15233019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-methyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus: treatment response to plasmapheresis.
    Smith JH; Dhamija R; Moseley BD; Sandroni P; Lucchinetti CF; Lennon VA; Kantarci OH
    Arch Neurol; 2011 Aug; 68(8):1069-72. PubMed ID: 21825245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Paraneoplastic neurological syndrome in 12 children].
    Xiao J; Liu LY; Wu Y; Han TL; Wang X
    Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):598-600. PubMed ID: 23158737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma.
    Burke MJ; Cohn SL
    Pediatr Blood Cancer; 2008 Mar; 50(3):679-80. PubMed ID: 16900484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Opsoclonus-myoclonus syndrome in children].
    Petrukhin AS; Bembeeva RTs; Samoĭlova MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(2):63-6. PubMed ID: 16548379
    [No Abstract]   [Full Text] [Related]  

  • 33. Opsoclonus-myoclonus syndrome as a paraneoplastic manifestation of renal cell carcinoma. a case report and review of the literature.
    De Luca S; Terrone C; Crivellaro S; De Zan A; Polo P; Vigliani MC; Tizzani A
    Urol Int; 2002; 68(3):206-8. PubMed ID: 11919472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opsoclonus-myoclonus syndrome in a child with neuroborreliosis.
    Vukelic D; Bozinovic D; Morovic M; Tesovic G; Ruzic Sabljic E; Barisic N; Knezovic I
    J Infect; 2000 Mar; 40(2):189-91. PubMed ID: 10841099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paraneoplastic Opsoclonus-Myoclonus Syndrome: initial presentation of non-Hodgkins lymphoma.
    Kumar A; Lajara-Nanson WA; Neilson RW
    J Neurooncol; 2005 May; 73(1):43-5. PubMed ID: 15933816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapy with plasmapheresis and lymphoplasmapheresis combined with immunosuppressive agents in 2 cases of intractable juvenile rheumatoid arthritis].
    Lepore L; Agosti E; Pitacco F; Panizon F
    Pediatr Med Chir; 1987; 9(3):321-4. PubMed ID: 3671132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paraneoplastic disorders of the central and peripheral nervous systems.
    Didelot A; Honnorat J
    Handb Clin Neurol; 2014; 121():1159-79. PubMed ID: 24365410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Opsoclonus myoclonus syndrome: how long are we going to go on researching?].
    Ramos S; Temudo T
    Rev Neurol; 2002 Aug 16-31; 35(4):322-5. PubMed ID: 12235560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Paraneoplastic neurological syndromes].
    Didelot A; Honnorat J
    Rev Med Interne; 2011 Oct; 32(10):605-11. PubMed ID: 21036427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opsoclonus-myoclonus syndrome associated with a nasopharyngeal tumor in an adult: a case report.
    Taib BG; Kinshuck AJ; Milburn-McNulty P; Fratalia L; Forsyth L; Husband D; Jones TM; Jacob A
    J Med Case Rep; 2015 Jun; 9():128. PubMed ID: 26033370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.